Abstract
Artificial skin substitutes based on cultured autologous keratinocytes need to have sufficient strength and ease of handling to be utilized successfully by surgeons in the clinic. This may be achieved by crosslinking the collagen substratum on which the cells are cultured, which in this case is a collagen gel. Increased strength must be attained without detrimental effect on cell growth. The influence of potential crosslinking agents including the glycosaminoglycan, chondroitin-6-sulphate (Ch6SO4), the water soluble carbodiimide crosslinking agents 1-ethyl-3-(3-diaminopropyl) carbodiimide (EDAC), and 1,1-carbonyldiimidazole (CDI), and the polyamines putrescine, spermine and diaminohexane, on cell growth rate has been investigated. Incorporation of 20% Ch6SO4 into collagen gels caused an approximately 16% increase in keratinocyte growth, but had no significant effect on that of dermal fibroblasts. Pre-formed collagen gels (+/− Ch6SO4) were treated with the carbodiimides. This crosslinking treatment markedly inhibited fibroblast growth (EDAC 45% inhibition, CDI 70%), without affecting that of keratinocytes. Pre-formed collagen gels (+/−Ch6SO4 and carbodiimide) were treated with 0.1 M, 0.5 M or 1.0 M polyamine. Spermine inhibited the growth rate of both cell types at all concentrations tested, whereas putrescine and diaminohexane had little effect. The mechanical strength of these crosslinked gels is currently being assessed to determine the optimum composition in terms of cell growth and biocompatibility, and strength.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
J. G. RHEINWALD and H. GREEN, Cell 6 (1975) 331.
V. FALANGA, J. Dermatol. 19 (1992) 667.
K. HASHIMOTO and K. YOSHIKAWA, ibid. 19 (1992) 648.
S. T. BOYCE and J. F. HANSBROUGH, Surgery 103 (1988) 421.
Y. KUROYANGI, M. KENMOCHI, S. ISHIHARA, A. TAKEDA, A. SHIRAISHI, N. OOTAKE, E. UCHINUMA, K. TORIKAI and N. SHIOYA, Ann. Plast. Surg. 31 (1983) 340.
T. MIYATA, T. TIARA and Y. NOISHIKI, Clin. Mater. 9 (1992) 139.
K. WEADOCK, R. M. OLSON and F. H. SILVER, Biomat. Med. Dev. Art. Org. 11(1984) 293.
K. MATSUDA, S. SUZUKI, N. ISSHIKI, K. YOSHIOKA, T. OKADA and Y. IKADA, Biomaterials 11 (1990) 351.
M. HANTHAMRONGWIT, W. H. REID and M. H. GRANT, ibid. 17 (1996) 775.
Y. ITO, S. Q. LUI, M. NAKABAYASHI and Y. IMANISHI, ibid. 13 (1992) 789.
R. MARCHAND, S. WOERLY, L. BERTAND and N. VALDES, Brain Res. Bull. 30 (1993) 415.
L. H. H. OLDE DAMINK, P. J. DIJKSTRA, M. J. A. VAN LUYN, P. B. VAN WACHEM, P. NIEUWENHUIS and J. FEIJEN, Biomaterials 17 (1996) 775.
J. H. HICKOK and J. UITTO, J. Invest. Dermatol. 98 (1992) 327.
R. G. HAM, Biochem. Biophys. Res. Commun. 14 (1964) 753.
T. TAKEMOTO, Y. NAGAMATSU and T. OKA, Biochem. Biophys. Acta. 740 (1983) 73.
B. B. RUDKIN, P. S. MAMONT and N. SEILER, Biochem. J. 217 (1984) 731.
S. T. BOYCE and R. G. HAM, J. Invest. Dermatol. 81 (1983) 33.
M. HANTHAMRONGWIT, W. H. REID, J. M. COURTNEY and M. H. GRANT, Human Exp. Toxic. 13 (1994) 423.
T. ELSDALE and J. BARD, J. Cell Biol. 54 (1972) 626.
D. P. SPEER, M. MHVAPIL, C. D. ESKELSON and J. ULREICH, J. Biomed. Mater. Res. 14 (1980) 753.
V. G. BRUNTON, M. H. GRANT and H. M. WALLACE, Biochem. Pharmacol. 40 (1990) 749.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
OSBORNE , C.S., REID , W.H. & GRANT , M.H. Investigation into cell growth on collagen/chondroitin-6-sulphate gels: the effect of crosslinking agents and diamines. Journal of Materials Science: Materials in Medicine 8, 179–184 (1997). https://doi.org/10.1023/A:1018579321414
Issue Date:
DOI: https://doi.org/10.1023/A:1018579321414